How big is the Virus Filtration Market?

The Virus Filtration Market size is expected to reach USD 1.43 billion in 2024 and grow at a CAGR of 7.37% to reach USD 2.04 billion by 2029. Read More

What is the current Virus Filtration Market size?

In 2024, the Virus Filtration Market size is expected to reach USD 1.43 billion. Read More

Who are the key players in Virus Filtration Market?

Asahi Kasei Medical Co. Ltd, Charles River Laboratories International Inc., Merck KgaA, Danaher Corporation and Qiagen are the major companies operating in the Virus Filtration Market. Read More

Which is the fastest growing region in Virus Filtration Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Virus Filtration Market?

In 2024, the North America accounts for the largest market share in Virus Filtration Market. Read More

What years does this Virus Filtration Market cover, and what was the market size in 2023?

In 2023, the Virus Filtration Market size was estimated at USD 1.32 billion. The report covers the Virus Filtration Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Virus Filtration Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Virus Filtration Market Share

Statistics for the 2023 & 2024 Virus Filtration market share, created by Mordor Intelligence™ Industry Reports. Virus Filtration share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Virus Filtration Industry

The virus filtration market is moderately competitive and consists of several major players. In terms of market share, few major players currently dominate the studied market. With the rising R&D of biopharmaceutical companies and the high prevalence of diseases, few other smaller players are expected to enter into the market studied in the coming years. Some of the market's major players studied are Asahi Kasei Medical Co. Ltd, Charles River Laboratories International Inc., Qiagen, Pall Corporation, and Merck KgaA, among others.